Literature DB >> 20844199

Differential modulation of TLR3- and TLR4-mediated dendritic cell maturation and function by progesterone.

Leigh A Jones1, Shrook Kreem, Muhannad Shweash, Andrew Paul, James Alexander, Craig W Roberts.   

Abstract

The role of progesterone in modulating dendritic cell (DC) function following stimulation of different TLRs is relatively unknown. We compared the ability of progesterone to modulate murine bone marrow-derived DC cytokine production (IL-6 and IL-12) and costimulatory molecule expression (CD40, CD80, and CD86) induced by either TLR3 or TLR4 ligation and determined whether activity was via the progesterone receptor (PR) or glucocorticoid receptor (GR) by comparative studies with the PR-specific agonist norgestrel and the GR agonist dexamethasone. Progesterone was found to downregulate, albeit with different sensitivities, both TLR3- and TLR4-induced IL-6 production entirely via the GR, but IL-12p40 production via either the GR or PR. Of particular significance was that progesterone was able to significantly inhibit TLR3- but not TLR4-induced CD40 expression in bone marrow-derived DCs. Stimulation of the PR (with progesterone and norgestrel) by pretreatment of DCs was found to sustain IFN regulatory factor-3 phosphorylation following TLR3 ligation, but not TLR4 ligation. Overall, these studies demonstrate that progesterone can differentially regulate the signaling pathways employed by TLR3 and TLR4 agonists to affect costimulatory molecule expression and cytokine production.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20844199     DOI: 10.4049/jimmunol.0901155

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  34 in total

Review 1.  Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis.

Authors:  Dionne P Robinson; Sabra L Klein
Journal:  Horm Behav       Date:  2012-03-03       Impact factor: 3.587

Review 2.  Immune cells have sex and so should journal articles.

Authors:  Sabra L Klein
Journal:  Endocrinology       Date:  2012-03-20       Impact factor: 4.736

Review 3.  Sex bias in autoimmunity.

Authors:  Allison C Billi; J Michelle Kahlenberg; Johann E Gudjonsson
Journal:  Curr Opin Rheumatol       Date:  2019-01       Impact factor: 5.006

Review 4.  Modulation of autoimmune rheumatic diseases by oestrogen and progesterone.

Authors:  Grant C Hughes; Divaker Choubey
Journal:  Nat Rev Rheumatol       Date:  2014-08-26       Impact factor: 20.543

Review 5.  Progesterone-based compounds affect immune responses and susceptibility to infections at diverse mucosal sites.

Authors:  Olivia J Hall; Sabra L Klein
Journal:  Mucosal Immunol       Date:  2017-04-12       Impact factor: 7.313

Review 6.  Sex differences in immune responses.

Authors:  Sabra L Klein; Katie L Flanagan
Journal:  Nat Rev Immunol       Date:  2016-08-22       Impact factor: 53.106

7.  Altered IgG autoantibody levels and CD4(+) T cell subsets in lupus-prone Nba2 mice lacking the nuclear progesterone receptor.

Authors:  Alan H Wong; Nalini Agrawal; Grant C Hughes
Journal:  Autoimmunity       Date:  2015-04-10       Impact factor: 2.815

Review 8.  Progesterone and autoimmune disease.

Authors:  Grant C Hughes
Journal:  Autoimmun Rev       Date:  2011-12-13       Impact factor: 9.754

9.  Effect of Depot Medoxyprogesterone Acetate on Immune Functions and Inflammatory Markers of HIV-Infected Women.

Authors:  Adriana Weinberg; Jeong-Gun Park; Ronald Bosch; Alice Cho; Elizabeth Livingston; Fran Aweeka; Yoninah Cramer; D Heather Watts; Amneris E Luque; Susan E Cohn
Journal:  J Acquir Immune Defic Syndr       Date:  2016-02-01       Impact factor: 3.731

10.  Dendritic cell activation and memory cell development are impaired among mice administered medroxyprogesterone acetate prior to mucosal herpes simplex virus type 1 infection.

Authors:  Rodolfo D Vicetti Miguel; Robert L Hendricks; Alfredo J Aguirre; Melissa A Melan; Stephen A K Harvey; Tracy Terry-Allison; Anthony J St Leger; Angus W Thomson; Thomas L Cherpes
Journal:  J Immunol       Date:  2012-08-31       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.